FindTrial
Sign In

ADD-ON DIGOXIN IN ARNI INTOLERANT PATIENTS OF HEART FAILURE

ADD-ON DIGOXIN IN ARNI INTOLERANT PATIENTS IN HFREF: A MULTICENTRAL,RANDOMISED OPEN LABEL, CONTROLLED TRIAL - DIGARNI TRIAL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/04/108037
Enrollment
1000
Registered
2026-04-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I429- Cardiomyopathy, unspecified

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil Control Intervention1: DIGOXIN ADD ON ARNI: ADDING DIGOXIN ON TOP OF ARNI WITH GDMT IN HEART FAILURE

Sponsors

Hakim Irfan Showkat
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: AGE : MORE THAN 18 YEARS GENDER: BOTH

Exclusion criteria

Exclusion criteria: AGE: LESS THAN 18 YEARS GENDER: NONE

Design outcomes

Primary

MeasureTime frame
1. ADMISSION 2.MACE 3. TITRATION OF DOSE Timepoint: 1. 2 WEEKS 2. 4 WEEKS 3. 12 WEEKS 4. 24 WEEKS 5. 48 WEEKS—

Secondary

MeasureTime frame
1. MORTALITY 2. QUALITY OF LIFE 3. MORBIDITYTimepoint: 2 WEEKS 4 WEEKS 12 WEEKS 24 WEEKS 48 WEEKS—

Countries

India

Contacts

Public ContactHAKIM IRFAN SHOWKAT

SRINAGAR MEDCITY HEART INSTITUTE

shahiresearch@gmail.com09990390305

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026